255 related articles for article (PubMed ID: 20660502)
1. Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines.
Brown I; Cascio MG; Wahle KW; Smoum R; Mechoulam R; Ross RA; Pertwee RG; Heys SD
Carcinogenesis; 2010 Sep; 31(9):1584-91. PubMed ID: 20660502
[TBL] [Abstract][Full Text] [Related]
2. The ω-3 endocannabinoid docosahexaenoyl ethanolamide reduces seizure susceptibility in mice by activating cannabinoid type 1 receptors.
Ghanbari MM; Loron AG; Sayyah M
Brain Res Bull; 2021 May; 170():74-80. PubMed ID: 33581310
[TBL] [Abstract][Full Text] [Related]
3. Omega-3 PUFA ethanolamides DHEA and EPEA induce autophagy through PPARγ activation in MCF-7 breast cancer cells.
Rovito D; Giordano C; Vizza D; Plastina P; Barone I; Casaburi I; Lanzino M; De Amicis F; Sisci D; Mauro L; Aquila S; Catalano S; Bonofiglio D; Andò S
J Cell Physiol; 2013 Jun; 228(6):1314-22. PubMed ID: 23168911
[TBL] [Abstract][Full Text] [Related]
4. Anticancer effects of n-3 EPA and DHA and their endocannabinoid derivatives on breast cancer cell growth and invasion.
Brown I; Lee J; Sneddon AA; Cascio MG; Pertwee RG; Wahle KWJ; Rotondo D; Heys SD
Prostaglandins Leukot Essent Fatty Acids; 2020 May; 156():102024. PubMed ID: 31679810
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid receptor as a novel target for the treatment of prostate cancer.
Sarfaraz S; Afaq F; Adhami VM; Mukhtar H
Cancer Res; 2005 Mar; 65(5):1635-41. PubMed ID: 15753356
[TBL] [Abstract][Full Text] [Related]
6. FAAH inhibition enhances anandamide mediated anti-tumorigenic effects in non-small cell lung cancer by downregulating the EGF/EGFR pathway.
Ravi J; Sneh A; Shilo K; Nasser MW; Ganju RK
Oncotarget; 2014 May; 5(9):2475-86. PubMed ID: 24811863
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid receptor antagonists and fatty acids alter endocannabinoid system gene expression and COX activity.
Kim J; Watkins BA
J Nutr Biochem; 2014 Aug; 25(8):815-23. PubMed ID: 24854955
[TBL] [Abstract][Full Text] [Related]
8. Endocannabinoids are expressed in bone marrow stromal niches and play a role in interactions of hematopoietic stem and progenitor cells with the bone marrow microenvironment.
Jiang S; Zagozdzon R; Jorda MA; Parmar K; Fu Y; Williams JS; Wood JA; Makriyannis A; Banu N; Avraham S; Groopman JE; Avraham HK
J Biol Chem; 2010 Nov; 285(46):35471-8. PubMed ID: 20826813
[TBL] [Abstract][Full Text] [Related]
9. β-Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB₁ or CB₂ receptors.
Benito C; Tolón RM; Castillo AI; Ruiz-Valdepeñas L; Martínez-Orgado JA; Fernández-Sánchez FJ; Vázquez C; Cravatt BF; Romero J
Br J Pharmacol; 2012 Jun; 166(4):1474-89. PubMed ID: 22321194
[TBL] [Abstract][Full Text] [Related]
10. Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors.
Desroches J; Charron S; Bouchard JF; Beaulieu P
Neuropharmacology; 2014 Feb; 77():441-52. PubMed ID: 24148808
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent.
Sreevalsan S; Joseph S; Jutooru I; Chadalapaka G; Safe SH
Anticancer Res; 2011 Nov; 31(11):3799-807. PubMed ID: 22110202
[TBL] [Abstract][Full Text] [Related]
12. Temporal and spatial distribution of the cannabinoid receptors (CB1, CB2) and fatty acid amide hydroxylase in the rat ovary.
Bagavandoss P; Grimshaw S
Anat Rec (Hoboken); 2010 Aug; 293(8):1425-32. PubMed ID: 20665820
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the CB
Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
[TBL] [Abstract][Full Text] [Related]
14. Inhibiting fatty acid amide hydrolase normalizes endotoxin-induced enhanced gastrointestinal motility in mice.
Bashashati M; Storr MA; Nikas SP; Wood JT; Godlewski G; Liu J; Ho W; Keenan CM; Zhang H; Alapafuja SO; Cravatt BF; Lutz B; Mackie K; Kunos G; Patel KD; Makriyannis A; Davison JS; Sharkey KA
Br J Pharmacol; 2012 Mar; 165(5):1556-71. PubMed ID: 21883147
[TBL] [Abstract][Full Text] [Related]
15. Hind limb suspension and long-chain omega-3 PUFA increase mRNA endocannabinoid system levels in skeletal muscle.
Hutchins-Wiese HL; Li Y; Hannon K; Watkins BA
J Nutr Biochem; 2012 Aug; 23(8):986-93. PubMed ID: 22051448
[TBL] [Abstract][Full Text] [Related]
16. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.
Di Marzo V; Melck D; Orlando P; Bisogno T; Zagoory O; Bifulco M; Vogel Z; De Petrocellis L
Biochem J; 2001 Aug; 358(Pt 1):249-55. PubMed ID: 11485574
[TBL] [Abstract][Full Text] [Related]
17. 5-lipoxygenase mediates docosahexaenoyl ethanolamide and N-arachidonoyl-L-alanine-induced reactive oxygen species production and inhibition of proliferation of head and neck squamous cell carcinoma cells.
Park SW; Hah JH; Oh SM; Jeong WJ; Sung MW
BMC Cancer; 2016 Jul; 16():458. PubMed ID: 27411387
[TBL] [Abstract][Full Text] [Related]
18. Presence and regulation of cannabinoid receptors in human retinal pigment epithelial cells.
Wei Y; Wang X; Wang L
Mol Vis; 2009 Jun; 15():1243-51. PubMed ID: 19547718
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of COX-2-mediated eicosanoid production plays a major role in the anti-inflammatory effects of the endocannabinoid N-docosahexaenoylethanolamine (DHEA) in macrophages.
Meijerink J; Poland M; Balvers MG; Plastina P; Lute C; Dwarkasing J; van Norren K; Witkamp RF
Br J Pharmacol; 2015 Jan; 172(1):24-37. PubMed ID: 24780080
[TBL] [Abstract][Full Text] [Related]
20. Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia.
Lichtman AH; Shelton CC; Advani T; Cravatt BF
Pain; 2004 Jun; 109(3):319-327. PubMed ID: 15157693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]